Evidence map›Paper›PMID 39185791›Full record

ReviewBioanalysis2024

Optimized LC-MS/MS methods for quantifying antibody-drug conjugate payloads in cell culture media containing phenol red.

Rachel E Foreman, Richard Lucey, Adam R Leaney, Mi-Young Lee, Humaira Naseer, Amanda Wilson

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Bioanalysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cell-Free DNA-Based Theranostics for Inflammatory Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rachel E ForemanIntegrated Bioanalysis, Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA.ORCID 0000-0001-9491-6789
Richard LuceyIntegrated Bioanalysis, Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA.
Adam R LeaneyIntegrated Bioanalysis, Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA.
Mi-Young LeeIntegrated Bioanalysis, Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA.
Humaira NaseerIntegrated Bioanalysis, Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA.
Amanda WilsonIntegrated Bioanalysis, Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA.ORCID 0000-0002-2659-1799

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Culture MediaImmunoconjugatesPhenolsulfonphthaleinTandem Mass SpectrometryChromatography, LiquidHumansLiquid Chromatography-Mass SpectrometrySolid Phase ExtractionCulture MediaImmunoconjugatesPhenolsulfonphthaleinbioanalytical extractioncell culture mediain vitro assaysliquid chromatographymass spectrometryphenol redsolid phase extraction

Identifiers

PMID39185791
PMCPMC11352794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.